Akebia Therapeutics
AKBA
AKBA
119 hedge funds and large institutions have $593M invested in Akebia Therapeutics in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 56 increasing their positions, 16 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 118 → 119 (+1)
0.19% less ownership
Funds ownership: 64.17% → 63.98% (-0.19%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
119
Holding in Top 10
2
Calls
$2.2M
Puts
$222K
Top Buyers
| 1 | +$19.8M | |
| 2 | +$10.4M | |
| 3 | +$9.19M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$7.8M |
| 5 |
Renaissance Technologies
New York
|
+$7.78M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$12M | |
| 3 | -$9.44M | |
| 4 |
First Manhattan
New York
|
-$5.43M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$4.82M |